期刊文献+

急性髓系白血病患者骨髓杯状核细胞阳性与FMS样酪氨酸激酶3基因内部串联重复突变相关性的Meta分析

Meta analysis on the relationship between cuplike nuclei morphology and FLT3-ITD mutation in acute myeloid leukemia
原文传递
导出
摘要 目的评价急性髓系白血病(AML)患者骨髓杯状核细胞阳性与FMS样酪氨酸激酶3基因内部串联重复(FLT3-ITD)突变的相关性。方法检索国内外各类大型数据库中2000年至2011年发表的有关AML患者杯状核细胞阳性与发生FLT3-ITD突变关系的文献,采用Meta分析方法,利用Statal1软件评价杯状核细胞阳性与FLT3-ITD突变之间的关系。计算OR值及其95%CI,Begg检验法和Egger检验法评价发表性偏倚。结果共纳入4篇文献,包括225例患者,其中杯状核细胞阳性的AML患者76例,杯状核阴性的AML患者149例(所有研究的AML患者均除外AML-M3、M5型)。对总体人群进行Meta分析,发现骨髓杯状核细胞阳性与FLT3.ITD突变的发生密切相关(OR=2.59,95%C11.55—4.33,P=0.00)。结论AML患者杯状核阳性与FLT3.ITD突变相关,该形态学特点可以指导临床医生合理选择检测项目。杯状核细胞阳性的患者也许可以成为AML的一种新亚型。 Objective To investigate the association between cuplike nuclei morphology and FLT3-ITD mutation, so as to provide evidence for the minor classification of AML. Methods The articles on the association of cuplike nuclei morphology and FLT3-ITD mutation were retrieved by searching international and national databases from 1999 to 2011. The relationship was assessed by meta analysis with Statal 1 software. The OR value and confidence interval (Co were calculated, and the publication bias was assessed by Begg test and Egger test. Results There was significant difference between cuplike nuclei morphology appearance and FLT3-ITD mutation (OR = 2.59, 95 % CI 1.55-4.33, P = 0.00). Results from both Begg's test and Egger' s test did not show significant difference indicating that there was no publication bias existed.Conclusion The uncommon morphologic variant of AML with cuplike nuclei is highly associated with FLT3-ITD mutation, and the presence of cuplike nuclei in AML represents a distinctive morphologic finding that can be used to prioritize the molecular workup of patients with AML.
出处 《白血病.淋巴瘤》 CAS 2012年第2期98-100,104,共4页 Journal of Leukemia & Lymphoma
基金 沈阳市血液病肿瘤研究重点实验室建设项目(F10-218-1-00)
关键词 META分析 杯状核细胞 白血病 髓样 急性 FLT3-ITD突变 Meta analysis Cuplike nuclei cell Leukemia, myeloid, acute FLT3-ITD mutation
  • 相关文献

参考文献15

  • 1Chen W, Rassidakis GZ, Li J, et al. High frequency of NPM1 gene mutations in acute myeloid leukemia with prominent nuclear invaginations ("cuplike" nuclei). Blood, 2006, 108: 1783-1784.
  • 2Kussick SJ, Stirewah DL, Yi HS, et al. A distinctive nuclear morphology in acute myeloid leukemia is strongly associated with loss of HLA-DR expression and FLT3 internal tandem duplication. Leukemia, 2004, 18: 1591-1598.
  • 3Kroschinsky FP, Schakel U, Fischer R, et al. Cup-like acute myeloid leukemia:new disease or artificial phenomenon? Haematologica, 2008, 93: 283-286.
  • 4Chen W, Konoplev S, Medeiros LJ, et al. Cuplike nuclei (prominent nuclear invaginations) in acute myeloid leukemia are highly associated with FLT3 internal tandem duplication and NPM1 mutation. Cancer, 2009, 115: 5481-5489.
  • 5McCormick SR, McCormick MJ, Grutkoski PS, et al. FLT3 mutations at diagnosis and relapse in acute myeloid leukemia: eytogenetic and pathologic correlations, including cuplike blast morphology. Arch Pathol Lab Med, 2010, 134: 1143-1151.
  • 6Rakheja D, Konoplev S, Su M, et al. High incidence of IDH mutations in acute myeloid leukaemia with cuplike nuclei. Br J Hacmatol, 2011, doi: 10.1111/j. 1365-2141.2011.08646.
  • 7Thiede C, Steudel C, Mohr B, et al. Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis. Blood, 2002, 99: 4326-4335.
  • 8Schnittger S, Schoch C, Dugas M, et al. Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease. Blood, 2002, 100: 59-66.
  • 9Preudhomme C, Sagot C, Boissel N, et al. Favorable prognostic significance of CEBPA mutations in patients with de novo acute myeloid leukemia: a study from the acute leukemia french association (ALFA). Blood, 2002, 100: 2717-2723.
  • 10Mrozek K, Marcucci G, Paschka P, et al. Clinical relevance of mutations and gene-expression changes in adult acute myeloid leukemia with normal cytogenetics: are we ready for a prognostically prioritized molecular classification? Blood, 2007, 109:431-448.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部